Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Keyphrases
Children with Cancer
100%
Antibiotics
100%
Infections in children
100%
Tunneled Central Venous Catheter
100%
Systemic Antibiotics
100%
Catheter-related Bloodstream Infection (CRBSI)
100%
Randomized Controlled Trial
45%
Adverse Events
36%
Controlled Clinical Trial
36%
Central Venous Catheter
27%
Urokinase
27%
Antibiotic Lock Therapy
27%
International Society
18%
Ethanol Lock
18%
Control Intervention
18%
Pediatric Oncology
9%
Selection Criteria
9%
Cochrane Library
9%
Embase
9%
Catheter
9%
MEDLINE
9%
Ethanol
9%
Sepsis
9%
Multinational Association of Supportive Care in Cancer
9%
Number of Participants
9%
Hematology
9%
Clinical Heterogeneity
9%
National Institutes of Health
9%
Risk of Bias Assessment
9%
Ongoing Trials
9%
Ovid
9%
Conference Proceedings
9%
Cochrane Central Register of Controlled Trials
9%
Thrombosis
9%
Salvage Value
9%
Methodological Limitations
9%
High Concentration
9%
American Society of Clinical Oncology
9%
American Society of Hematology
9%
Low Power
9%
Search Methods
9%
Difficult-to-treat
9%
Systemic Concentration
9%
Number of Days
9%
Issue 3
9%
Antibiotic Efficacy
9%
ICU Admission
9%
Biofilm Formation
9%
Extracted Data
9%
Cochrane Handbook
9%
Health Registers
9%
Negative Blood Culture
9%
Infection Range
9%
Medicine and Dentistry
Malignant Neoplasm
100%
Catheter Infection
100%
Central Venous Catheter
100%
Antimicrobial Agent
100%
Antibiotics
100%
Randomized Controlled Trial
45%
Cohort Studies
45%
Adverse Event
36%
Controlled Clinical Trial
36%
Urokinase
27%
Alcohol
27%
Hematology
18%
Childhood Cancer
9%
Systematic Review
9%
Infection
9%
Supportive Care
9%
Thrombosis
9%
Sepsis
9%
Blood Culture
9%
Clinical Oncology
9%
Pharmacology, Toxicology and Pharmaceutical Science
Malignant Neoplasm
100%
Catheter Infection
100%
Antibiotics
100%
Antimicrobial Agent
100%
Randomized Controlled Trial
45%
Cohort Study
45%
Adverse Event
36%
Controlled Clinical Trial
36%
Urokinase
27%
Ethanol
27%
Childhood Cancer
9%
Infection
9%
Sepsis
9%
Thrombosis
9%
Nursing and Health Professions
Urokinase
42%
Biofilm
14%